Contents13 sections
BPC-157 and TB500 are the two peptides people ask about most when an injury refuses to heal. Both are linked to faster tissue repair in lab and animal research, both are popular with athletes, and both are often sold together in one vial.
TB500 is a synthetic peptide based on thymosin beta-4, a protein the body uses to help cells move into damaged tissue. BPC-157 is a short synthetic peptide taken from a protein found in human gastric juice. They are often grouped together, but they are different molecules with different research behind them.
This comparison of TB500 vs. BPC157 covers how each one works, what the research actually shows (and how much of it is animal data), commonly reported doses, side effects, the BPC-157 + TB-500 blend, and which one fits which kind of injury.
Key Takeaways
- TB-500 is based on thymosin beta-4, a 43-amino-acid protein involved in cell movement and repair; BPC-157 is a 15-amino-acid fragment of a protein found in gastric juice.
- Almost all the evidence for both comes from cell and animal studies. Neither has completed large controlled human trials for sports injuries.
- BPC-157 has the larger body of animal research on tendons, ligaments, muscle and the gut; thymosin beta-4 research centres on skin wounds, the heart and the eye.
- TB-500 is used by injection; capsule and patch versions have no supporting data. Commonly reported doses for both come from user reports, not clinical trials.
- Both are unapproved and WADA-prohibited. They are often combined in a BPC-157 + TB-500 blend, but the combination has not been tested in controlled studies.
Comparison of TB500 vs. BPC157
| Property | TB500 | BPC-157 |
|---|---|---|
| What it is | Synthetic peptide based on thymosin beta-4 (43 amino acids). Some products sold as TB-500 contain only a short fragment of it (amino acids 17-23). | Synthetic peptide of 15 amino acids, a partial sequence of a protein found in human gastric juice |
| Molecular weight | About 4,963 g/mol (full-length thymosin beta-4) | About 1,419 g/mol |
| Main mechanism | Binds actin, helping cells migrate into damaged tissue; supports new blood vessel growth and dampens inflammation | Supports new blood vessel growth and growth-factor signalling; increases tendon cell migration and survival in lab studies |
| Main research areas | Skin wounds, heart injury, eye (cornea) repair, hair follicles | Tendon, ligament, muscle and bone healing; stomach and gut lesions |
| Evidence level | Mostly cell and animal studies; small human trials of full-length thymosin beta-4 as eye drops and wound gels | Mostly rat studies; human data limited to a few small, uncontrolled reports |
| Form used | Injectable powder (subcutaneous or intramuscular) | Injectable powder; also taken orally, as it is stable in gastric juice |
| Safety | Few side effects reported, but limited human data and unknown long-term safety. See our guide to peptide side effects. | Few side effects seen in animal studies; long-term human safety is unknown |
| Regulatory status | Not approved for human use; prohibited by WADA | Not approved for human use; prohibited by WADA |
Peptide Profiles: TB500 vs. BPC157
TB500 at a Glance
- Main interest: recovery from muscle, skin and soft-tissue injuries
- Form: freeze-dried powder, reconstituted and injected under the skin or into muscle. Oral capsules and transdermal patches are marketed, but there is no reliable evidence that they deliver the peptide.
- Commonly reported dose: about 4-5 mg per week, split into two injections, for 4-6 weeks, then a lower maintenance dose (often 2-2.5 mg once a week or every other week). These figures come from user reports, not clinical trials.
- Typical reported cycle: 6-8 weeks in total, including the maintenance phase
- Reported side effects: redness or irritation at the injection site, headache, tiredness
- Often combined with: BPC-157
- Full guide: TB-500: Benefits, Dosage, and Recovery Guide
TB500 is a synthetic peptide modelled on thymosin beta-4. The name is a product label rather than an abbreviation: thymosin beta-4 is a natural 43-amino-acid protein found in almost every cell and in high amounts in blood platelets and wound fluid. Thymosin beta-4 has been studied extensively in lab and animal models of tissue repair [1].
Its best-understood job is binding actin, the protein that forms a cell’s internal scaffolding. That lets cells move, and it is the reason thymosin beta-4 is linked to cell migration into damaged tissue, new blood vessel growth and lower inflammation.
Be aware that “TB-500” is used loosely. Some products contain the full 43-amino-acid sequence, while the anti-doping literature uses the name for a short synthetic fragment of the active region (amino acids 17-23). The label and a certificate of analysis tell you which one you are looking at.
Overview
- Form: Lyophilized powder
- Researched Dosage: 2 mg to 5 mg per week, often split into two doses, during a 4-6 week loading phase; then 2 mg to 2.5 mg every 1-2 weeks for maintenance
- Typical Cycle: 4-8 weeks
- Cost: $23.96-$25.16
- Stacking Options: BPC-157, GHK-Cu, CJC-1295/Ipamorelin
Pros
- Thought to help regulate actin, a protein involved in cell movement and structure, which may help with tissue repair and recovery.
- Animal studies suggest it may speed up healing in muscle, tendon, ligament and skin, and may reduce inflammation.
- Commonly paired with BPC-157 because the two peptides are believed to support recovery in different ways.
Cons
- May encourage new blood vessel growth and cell migration, which raises a theoretical concern about speeding up existing tumors. Long-term human safety data is very limited.
- Not an approved human medication. The FDA lists it as a bulk substance with potential safety risks (Category 2), and WADA bans it for tested athletes.
BPC157 at a Glance
- Main interest: tendon, ligament and muscle injuries, and gut problems
- Form: injectable powder (subcutaneous, often near the injury); oral capsules are also sold, and many rat studies gave it orally. Nasal sprays exist but have little supporting data.
- Commonly reported dose: 250-500 mcg per day, sometimes split into two doses, for 4-8 weeks (user reports, not clinical trials)
- Reported side effects: injection-site irritation, nausea, dizziness
- Often combined with: TB-500
- Compound page: BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide. Its sequence is a small part of a larger protein isolated from human gastric juice, which is why it is unusually stable in the stomach and could be tested orally in animals.
In animal and lab studies, BPC-157 appears to promote angiogenesis (the formation of new blood vessels) and to help cells move into injured areas. In tendon cells from rats, it increased cell migration, survival and growth hormone receptor expression.
Most of the BPC-157 literature comes from one research group at the University of Zagreb. The animal results are consistent, but independent replication and human trials are still missing.
Overview
- Form: Lyophilized powder for injection (5 mg or 10 mg vial)
- Researched Dosage: 250 mcg to 500 mcg daily, often split into two doses
- Typical Cycle: 4-6 weeks
- Cost: $52.00 (5 mg) to $92.00 (10 mg)
- Stacking Options: TB-500, GHK-Cu, KPV
Pros
- A peptide derived from a protein in gastric juice, studied for repairing tendon, ligament, muscle and gut tissue.
- Animal studies show faster healing of tendon-to-bone injuries and muscle tears, likely through new blood vessel growth.
- It is unusually stable in stomach acid, which is why it has also been studied for ulcers and gut inflammation.
Cons
- Nearly all of the evidence comes from animal studies; published human data is limited to a few small pilot reports.
- Because it promotes blood vessel growth, there is a theoretical concern it could feed existing tumors.
- The FDA lists it as a bulk substance with potential safety risks (Category 2), and WADA has banned it since 2022.
TB500 & BPC157 Peptides: Understanding Their Distinct Roles
Both peptides end up supporting the same broad process (getting blood supply and repair cells into damaged tissue), but they get there differently, and the research has looked at different tissues.
- TB500 works through actin and cell movement. It is thought to act throughout the body, which is why users describe it as a “systemic” recovery peptide. Animal research focuses on skin wounds, heart muscle after a heart attack, the cornea, hair follicles and nerve injury.
- BPC-157 appears to act on blood vessel growth, the nitric oxide system and growth-factor signalling. Animal research focuses on tendons, ligaments, muscle, bone and the gut lining, and many studies looked at a specific injury site.
Applications and Potential Uses of TB500
Wound Healing
Wound healing is the best-documented area for thymosin beta-4. In a rat wound model, thymosin beta-4 given topically or by injection sped up wound closure and increased new blood vessel growth and collagen deposition [2].
Better blood supply brings nutrients and immune cells to the injured area, and faster cell migration helps close the wound. Full-length thymosin beta-4 has been tested in small human trials as a topical gel for chronic skin wounds and as eye drops for corneal damage, with mixed results and no approved product so far [3]. Injected TB-500 for muscle tears or ligament damage has not been tested in human trials.
Muscle Recovery
Athletes use TB500 mainly to recover from strains and overuse injuries. The reasoning is that better blood flow and lower inflammation should help damaged muscle repair.
There is no good evidence that TB500 builds muscle or causes hypertrophy, and no human studies on recovery between workouts. Its use for athletic purposes remains experimental, and it is banned in tested sport.
Cardiac Repair and Protection
In mouse studies, thymosin beta-4 improved the survival of heart muscle cells after a heart attack and activated heart progenitor cells. These findings drove early interest in it as a heart therapy.
This is animal data. Human research on thymosin beta-4 for heart disease did not progress to an approved treatment, and nobody should use TB-500 to treat a heart condition.
Hair Growth
Mouse studies suggest thymosin beta-4 can activate hair follicle stem cells and speed up hair growth. There are no human studies of injected TB-500 for hair growth or alopecia, so this remains a lab finding.
Joint Health and Osteoarthritis
There is little direct research on TB500 for joint pain or osteoarthritis. The interest is extrapolated from its anti-inflammatory and tissue-repair effects in other tissues, not from joint studies.
Applications and Potential Uses of BPC 157
Wound Healing and Tissue Repair
In rat studies, BPC-157 has sped up the healing of skin wounds, burns and several soft tissues [4]. The proposed mechanisms are new blood vessel growth, which improves blood supply to the wound, and greater activity of fibroblasts, the cells that lay down collagen.
These results are why BPC-157 is popular for slow-healing injuries and post-surgery recovery, but they have not yet been confirmed in controlled human trials.
Muscle and Tendon Injuries
This is where BPC-157 has the most animal research. Rat studies of cut Achilles tendons, torn ligaments and crushed or damaged muscle reported faster and more complete healing with BPC-157 than without it.
In tendon cell cultures, BPC-157 increased cell migration and survival, which may help explain these results. Tendons heal slowly because they have a poor blood supply, so a compound that improves blood vessel growth in the area is a logical candidate. Whether this translates to people is still unproven.
Gastrointestinal Disorders
BPC-157 was first studied for the gut. In rat models of stomach ulcers, colitis and intestinal damage, it protected and healed the gastric and intestinal lining and reduced inflammation [5].
This has made it popular for gut complaints such as ulcers and inflammatory bowel disease, but there are no published controlled human trials for these conditions.
Joint Health and Arthritis
Rat studies on ligament and bone healing suggest BPC-157 may help repair joint structures. In people, the evidence is limited to small, uncontrolled reports of knee-pain patients who received BPC-157 injections. That is not enough to say it treats arthritis.
Protection Against NSAID-Induced Damage
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen relieve pain and inflammation, but they can damage the stomach and intestines [6].
In rats, BPC-157 counteracted the stomach and intestinal lesions caused by NSAIDs. There is no evidence that it makes NSAIDs work better, and no human data on combining the two.
Using TB-500 and BPC-157 Together: The Blend
BPC-157 and TB-500 are the most common peptide pairing for injuries, and many vendors sell them premixed as a BPC-157 + TB-500 blend. The reasoning is that the mechanisms are different and could complement each other: BPC-157 for local blood supply and tendon or ligament repair, TB-500 for cell migration and inflammation more broadly.
What to know before you consider it:
- No controlled studies: we are not aware of any published controlled study, in humans or animals, that tested the combination. The case for stacking is theory plus user reports.
- Fixed ratio: a premixed vial locks both doses together, so you cannot adjust one without the other. Users who want control usually buy the two separately.
- Unknowns add up: combining two compounds without long-term human safety data doubles the uncertainty, including the theoretical concern about promoting blood vessel growth in people with a history of cancer.
- Quality matters twice: a blend has to be tested for both peptides, so a certificate of analysis that lists both is the minimum.
TB500 vs. BPC157: Which to Choose?
Neither peptide is a proven treatment for any injury in people, so the honest answer is “what does the research cover?” rather than “which works better?”. Here is how the evidence lines up by goal:
| Goal | More research behind | Why |
|---|---|---|
| Tendon or ligament injury | BPC-157 | Most of its animal studies are on tendons and ligaments |
| Muscle strain | BPC-157 (both are used) | Rat muscle-injury studies for BPC-157; TB-500 use is based mainly on user reports |
| Gut lining, ulcers, NSAID damage | BPC-157 | It was first developed and studied for the gut |
| Skin wounds | Thymosin beta-4 / TB-500 | Animal studies plus small human trials of topical thymosin beta-4 |
| General, whole-body recovery | TB-500 (in user reports) | Thought to act systemically; no human data |
| Heart or eye repair | Thymosin beta-4 | Studied in animals and small eye-drop trials; not a self-treatment |
Whatever you read about peptides, a proper diagnosis and a structured rehab plan come first. Many tendon and muscle injuries heal well with load management and physiotherapy, and some need medical treatment that no peptide replaces. For a wider look at the options, see our guide to the best peptides for healing.
Safety, Dangers, and Regulatory Considerations
TB500
Safety: thymosin beta-4 showed low toxicity in preclinical studies and was well tolerated in its small human trials. Side effects reported by TB-500 users are usually mild: tiredness, headache and redness at the injection site. Long-term safety in humans is unknown.
Dangers: thymosin beta-4 promotes cell migration and blood vessel growth, and higher levels have been linked to tumour growth and spread in some cancer research. That makes it a theoretical concern for anyone with a current or past cancer. Self-dosing without medical supervision, unknown drug interactions and products of uncertain content add to the risk.
BPC 157
Safety: in animal studies BPC-157 has a low toxicity profile with few adverse effects. Most of this research was done in rats, and long-term human safety has not been established.
Dangers: because BPC-157 is sold as a research chemical, quality and purity vary, and there is a risk of underdosed or contaminated products. Like TB-500, it promotes blood vessel growth, so the same theoretical cancer concern applies.
Regulatory and Sport Status
Neither peptide is approved for human use by the FDA or other major regulators. Both are on the WADA Prohibited List and banned at all times: thymosin beta-4 and its derivatives such as TB-500 are listed as growth factors, and BPC-157 falls under non-approved substances. TB-500 is also a known doping agent in horse racing, where testing methods were developed for it.
Factors To Remember When Buying Peptides
- Legal status: both peptides are sold for research purposes only, and the rules differ by country.
- Quality and purity: buy only from suppliers that publish a third-party certificate of analysis (COA) for the batch. A COA confirms identity and purity; it does not make a product safe to use.
- Check what TB-500 contains: the label should say whether it is full-length thymosin beta-4 or a fragment.
- Handling: peptides degrade with heat and light, so proper storage and sterile reconstitution matter.
The Bottom Line
TB500 and BPC157 are both promising repair peptides in animal research, but neither is a proven injury treatment in humans.
- BPC-157 has the deeper animal evidence for tendon, ligament, muscle and gut injuries, which is why it is the one most often chosen for a specific, local injury.
- TB-500 is based on thymosin beta-4, which is best studied for skin, heart and eye repair; it is used by injection, and its reputation for whole-body recovery rests on user reports.
- Both are unapproved, WADA-prohibited research chemicals of variable quality, and the popular blend combines their unknowns. A diagnosis and proper rehab come first.
Frequently Asked Questions
Disclaimer
Please read carefully
The information on this site is for educational and informational purposes only, and is not medical advice. Always consult a qualified healthcare professional before using any supplement or medication, or making changes to your health, fitness, or nutrition routine.
Not medical advice
Content here is not a substitute for professional medical advice.
Consult your doctor
Talk to your doctor before starting any supplement or new routine.
Use at your own risk
We are not responsible for adverse effects from acting on this.
Do your research
Make informed decisions about your own health.
No guarantees
Individual results vary. No claims about outcomes.
Important — Never disregard professional medical advice or delay seeking it because of something you read here. If you think you may have a medical emergency, call your doctor or your local emergency number right away.
